Live from the NIH registry
Studies recruiting near Santa Clarita right now
Top 25 of 2,384 recruiting studies, sorted by proximity — each links to its official registry page
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (29.1 mi)
· Sponsor: University of Pennsylvania
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente - Panorama City — Panorama City, California (13.6 mi)
· Sponsor: SWOG Cancer Research Network
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Group of Southern California — Los Angeles, California (29.1 mi)
· Sponsor: Pacific Edge Limited
Assessing Improvements in Mood and Sleep Trial
Depression, Suicidality
N/A
Interventional 420 participants sought
The Regents of the University of California, Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: University of Pittsburgh
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
UCLA Care — Los Angeles, California (29.1 mi)
· Sponsor: Westat
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0135) — Burbank, California (19.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Beverly Hills Cancer Center — Beverly Hills, California (24.4 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Global Research Management — Glendale, California (23.5 mi)
· Sponsor: Boehringer Ingelheim
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Low-Risk, Early Stage Breast Cancer
N/A
Interventional 400 participants sought
Glendale Adventist Medical Center d/b/a Adventist Health Glendale — Glendale, California (23.5 mi)
· Sponsor: IceCure Medical Ltd.
Regional Blocks for Lateral Condyle Fractures
Fractures, Closed, Humeral Fractures
Phase 4
Interventional 90 participants sought
Orthopaedic Institute for Children — Los Angeles, California (29.1 mi)
· Sponsor: University of California, Los Angeles
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
California Eye Specialists Medical group Inc. — Pasadena, California (27.4 mi)
· Sponsor: Genentech, Inc.
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 168 participants sought
California Research Institute — Los Angeles, California (29.1 mi)
· Sponsor: OncoNano Medicine, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: National Cancer Institute (NCI)
Motivation for IV Alcohol Self-Administration in Humans
Alcohol Use Disorder
Phase 2
Interventional 210 participants sought
University of California, Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: University of California, Los Angeles
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Clinical Research Institute, LCC — Los Angeles, California (29.1 mi)
· Sponsor: AbbVie
Study Evaluating the Quality and Effects of Lion's Mane Product on Cognitive Health
Cognitive Decline
N/A
Observational 150 participants sought
People Science — Los Angeles, California (29.1 mi)
· Sponsor: M2 Ingredients
Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants
Movement Disorders, Neurorehabilitation
N/A
Interventional 50 participants sought
UCLA Neural Engineering and Computation Lab — Los Angeles, California (29.1 mi)
· Sponsor: University of California, Los Angeles
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Los Angeles, California (29.1 mi)
· Sponsor: Alkermes, Inc.
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
Acute Lymphoblastic Leukemia
N/A
Observational 500 participants sought
Los Angeles General Medical Center — Los Angeles, California (29.1 mi)
· Sponsor: University of Southern California
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma
Phase 1
Interventional 694 participants sought
USC Norris Comprehensive Cancer Center /ID# 279603 — Los Angeles, California (29.1 mi)
· Sponsor: AbbVie
PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
Postpartum Hypertension (PPHT)
Phase 4
Interventional 110 participants sought
UCLA Ronald Reagan — Los Angeles, California (29.1 mi)
· Sponsor: University of California, Los Angeles
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
Gastro Care Institute — Lancaster, California (28.2 mi)
· Sponsor: Genentech, Inc.
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
UCLA Santa Monica Hematology Oncology — Santa Monica, California (27.5 mi)
· Sponsor: Astellas Pharma Inc
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis
Children With Medical Complexity (CMC), Multiple Chronic Conditions
N/A
Interventional 110 participants sought
Children's Hospital Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: University of Utah
Intercostal Cryoanalgesia in Double Lung Transplant Recipients
Post-operative Pain Management
N/A
Interventional 148 participants sought
University of California Los Angeles — Los Angeles, California (29.1 mi)
· Sponsor: University of California, Los Angeles